For the first time in more than 30 years, the Society for Vascular Surgery, in joint sponsorship with the American Venous Forum, launched a new peer-reviewed journal in 2013, the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS: VL). Anton Sidawy, MD, and Bruce Perler, MD, editors of the Journal of Vascular Surgery, developed the concept for this journal and are serving as the inaugural editors of JVS: VL.
Drs. Sidawy and Perler stated the following in the first volume.
“Venous and lymphatic diseases are emerging as an increasingly important part of the spectrum of circulatory disease and clinical practice of comprehensive vascular specialists. We are in the midst of an unprecedented expansion in minimally invasive treatment options for the millions of individuals with venous disease. Just as our founding editors of the JVS recognized ‘unprecedented advances have been made in vascular surgery,’ which justified the establishment of that publication, we believed that unprecedented advances in venous disease merited a dedicated high quality premier academic journal devoted to the treatment of and research in venous and lymphatic diseases. We firmly believe that the JVS: VL will fill that void. We also believe that the JVS: VL will highlight the unparalleled leadership of vascular surgeons in the crowded field of specialists treating venous disease.”
JVS: VL, introduced as a quarterly publication, publishes the highest quality peer-reviewed clinical and research studies in the fields of venous and lymphatic disease, as well as similar special features to those found in the JVS. Published in the first volume of JVS: VL were:
• 43 peer-reviewed clinical studies
• three basic science studies
• 10 case reports
• seven vascular images
• three review articles
• two venous techniques
• two practice management articles
• and two historical vignettes.
In addition, abstracts from the 2013 Annual Meeting of the American Venous Forum were published in the January issue of the JVS: VL in advance of its annual meeting in February, 2013.
By all metrics, the JVS has become the pre-eminent publication in the world in the field of vascular surgery. The Impact Factor of the JVS is the highest among all vascular surgical journals and this past year received about 1,800 manuscript submissions, including more than half from outside the United States and North America.
“It is our expectation, and our firm commitment, to likewise see the JVS: VL become the pre-eminent international publication in the field of venous and lymphatic disorders, and to reflect the leadership of vascular surgeons in the research and clinical care of patients with these disorders,” said Drs. Sidawy and Perler.